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pancreatic pseudocysts.E
osinophilia, defined as greater than 450
eosinophils/L, can occur in various disease
processes, including infectious, allergic,
neoplastic, and primary hematologic disorders.1
Marked eosinophilia ([1500 eosinophils/L) can
be a diagnostic dilemma because blood eosino-
philia rarely exceeds 1500/L in atopic/allergic
diseases.1 Hyperimmunoglobulinemia E is seen in
allergic, parasitic, and primary immunodeficiency
diseases.2 Although a hallmark of allergic disease is
the infiltration of tissues with increased numbers of
eosinophils, there is little evidence for immuno-
globulin Eedependent function of eosinophils.2
Primary immunodeficiency disease, autosomal
dominant hyperimmunoglobulin E syndrome or
Job syndrome, is caused by mutations of STAT3
gene, and shows greater than 2000 IU/mL of a peak
serum immunoglobulin E, eosinophilia, and eczem-
atous dermatitis.3 Thus, T-cell immunodeficiency
also causes eosinophilia, hyperimmunoglobuline-
mia E, and eczematous dermatitis.
Pancreatic diseases occasionally cause eo-
sinophilia.4,5 Although both eosinophilia and
hyperimmunoglobulinemia E are linked with
eczematous dermatitis, skin manifestations associ-
ated with pancreatic diseases such as pancreatic
panniculitis are uncommon.6 We present a case of
a 60-year-old Japanese man with pancreatitis
and refractory eczematous dermatitis accompa-
nied with transient, marked eosinophilia andthe Division of Internal Medicine and Dermatology, Depart-
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titis completely resolved with treatment of his
pancreatic pseudocysts.
CASE REPORT
A previously healthy 60-year-old Japanese man
presented to the division of internal medicine with
dyspnea and left-sided chest pain. His past medical
history was only significant for excessive alcohol
consumption. On examination, he was tachycardic
and had slightly low pulse oximetry saturation with a
normal blood pressure range and body temperature.
Baseline laboratory results were as follows: while
blood cell count 9290/L (increased), serum total
protein 7.1 g/dL, serum albumin 3.8 g/dL, aspartate
aminotransferase 28 IU/mL, alanine aminotrans-
ferase 19 IU/L, alkaline phosphatase 285 IU/L,
g-GTP 53 IU/L (increased), and C-reactive protein
11.60 mg/dL (increased). Chest radiograph showed
infiltrates in the left lower lobe of the lung. He was
admitted to our division of internal medicine for
potential pneumonia.
His major symptom of chest pain resolved with
oral tosufloxacin (antibacterial) and diclofenac so-
dium. The initial computed tomography (CT) scan
showed ascites and an intraperitoneal abscess in the
left upper quadrant, which raised the potential
diagnosis of peritonitis. After resolution of chest
pain, he reported diffuse pruritus. Eosinophilia and
hyperimmunoglobulinemia E rapidly increased toInaokacho, Yokosuka, Kanagawa 238-8580, Japan. E-mail: ito.
toshiki@kdu.ac.jp.
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Fig 1. Patient’s clinical course from March 22 to August
30, 2012. The patient’s major symptom of chest pain
improved with oral tosufloxacin (TFLX ) treatment for
7 days. A downward-pointing arrow indicates his first
visit to the dermatology division. An upward-pointing
arrow indicates the computed tomography (CT ) scans:
first reveals ascites and an intraperitoneal abscess;
second indicates an accumulation of fluid in the tail
of the pancreas; and third (red arrow) indicates the
definite diagnosis of pancreatic pseudocysts. The first
admission is from March 22 to March 31, 2012. AMY,
Amylase; BBP, betamethasone butyrate propionate; DS,
diclofenac sodium; EO, eosinophils; HCl, hydrochloride;
dashed line, upper limit of normal peripheral blood
eosinophils.
Fig 2. Skin manifestations of lower aspect of patient’s left
leg on the first visit to the dermatology division. Licheni-
fied plaques and nodules with excoriations.
Fig 3. A coronal section of the enhanced third computed
tomography scan showing pancreatic pseudocysts (ar-
rows) with homogeneous low-density masses.
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(Fig 1). Repeat CT scan showed that the abscess in
the left upper quadrant was diminished in size, but
an accumulation of fluid appeared in the tail of
the pancreas. Because his pruritus and skin mani-
festations were worsening, he was referred to the
dermatology division.
On his first visit to the dermatology division, he
exhibited lichenified papules and plaques with
excoriations on his back and legs (Fig 2) and scaly
erythema on the scalp. A third CT scan confirmed
pancreatic pseudocysts. These CT findings sug-
gested that the causal factor of his disease was
pancreatic inflammation. Although he strongly
preferred supportive care for pancreatic pseudo-
cysts, the cysts were becoming larger (Fig 3) with
increasing amylase levels. In addition, his pruritus
and eczematous dermatitis were refractory to oral
olopatadine hydrochloride (antihistamine) and
topical betamethasone butyrate propionate. Finally,
ultrasound-guided percutaneous drainage (US-PD)
was performed to treat the cysts.
The patient’s pruritus temporally exacerbated
shortly after US-PD, but he began to respond to
treatment and the symptom improved. Approx-im-
ately 75% of his skin lesions resolved 6 months after
US-PD combined with an improvement of pancreatic
pseudocysts (Fig 4). Currently abstinent from alcohol,
he remains free of eczematous dermatitis with quies-
cent pancreatic pseudocysts.
DISCUSSION
Pancreatic pseudocysts are a delayed complica-
tion of acute or chronic pancreatitis that consist of
fluids containing pancreatic enzymes.7 Most pseu-
docysts resolve spontaneously with supportive care,
but symptomatic ones often require therapeutic
Fig 4. Skin manifestations of the lower aspect of patient’s
left leg 6 months after ultrasound-guided percutaneous
drainage. Lichenified plaques and nodules are consider-
ably improved.
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open surgery.7
Chronic pancreatitis was first reported to be
associated with eosinophilia in 1946.8 The incidence
of eosinophilia is between 15.6% (28 of 180 pa-
tients)4 and 17.2% (21 of 122 patients)5 during the
course of chronic pancreatitis. However, marked
peripheral blood eosinophilia is rarely associated
with chronic pancreatitis.1
In our case, we propose that pancreatic inflam-
mation may have caused skin manifestations for
the following reasons: (1) the patient did not have
any atopic/allergic diseases; (2) both eczematousdermatitis and pruritus were exacerbated with
pancreatic inflammation, including elevated serum
amylase levels (Fig 1); (3) after the patient’s pseu-
docysts were treated with US-PD, the skin manifes-
tations and pancreatic pseudocysts improved; and
(4) eczematous dermatitis resolved spontaneously
with quiescence of pancreatic pseudocysts as a
result of abstinence from alcohol. Taken together,
these data suggest that severity of skin manifesta-
tions may be correlated with the extent of pancreatic
pseudocysts.
In conclusion, pancreatic diseases, including
pancreatic pseudocysts, should be considered in
the differential diagnosis of refractory dermatitis
with eosinophilia and hyperimmunoglobulinemia E.
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